<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Immunotherapy has improved outcomes for non-small cell lung cancer, but durable benefits remain limited to a subset of patients.]]></title><description><![CDATA[<p>Immunotherapy has improved outcomes for non-small cell lung cancer, but durable benefits remain limited to a subset of patients. Emerging research points to neural elements within the tumor microenvironment as potential driver...</p><p><a href="https://www.bioscience.com.pk/en/subject/medicine/a-neural-related-transcriptional-signature-is-associated-with-reduced-immune-activity-and-pathological-response-to-neoadjuvant-chemo-immunotherapy-in-non-small-cell-lung-cancer" rel="nofollow noopener"><span>https://www.</span><span>bioscience.com.pk/en/subject/m</span><span>edicine/a-neural-related-transcriptional-signature-is-associated-with-reduced-immune-activity-and-pathological-response-to-neoadjuvant-chemo-immunotherapy-in-non-small-cell-lung-cancer</span></a></p><p><a href="https://mastodon.social/tags/Medicine" rel="tag">#<span>Medicine</span></a> <a href="https://mastodon.social/tags/MedicalScience" rel="tag">#<span>MedicalScience</span></a> <a href="https://mastodon.social/tags/Health" rel="tag">#<span>Health</span></a></p>]]></description><link>https://postcall.pub/topic/0f9baf8b-9ee9-4baf-a431-afd6d84b722b/immunotherapy-has-improved-outcomes-for-non-small-cell-lung-cancer-but-durable-benefits-remain-limited-to-a-subset-of-patients.</link><generator>RSS for Node</generator><lastBuildDate>Sun, 22 Nov 2026 22:25:59 GMT</lastBuildDate><atom:link href="https://postcall.pub/topic/0f9baf8b-9ee9-4baf-a431-afd6d84b722b.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 21 Nov 2026 13:16:27 GMT</pubDate><ttl>60</ttl></channel></rss>